Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma

Respiratory Medicine

Volumn 89, Issue 6, 1995, Pages 435-440

  Hewer, S Langton ^c   Hobbs, J ^a   French, D ^b   Lenney, W ^a  

^a ALEXANDRA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; PLACEBO; SALMETEROL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPIROMETRY; SYMPTOM;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; CHILD; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE;

EID: 0029011694     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/0954-6111(95)90213-9     Document Type: Article

References (29)

1. Choice of drug treatment in asthma
2. Aerolized bronchodilators and steroids in the treatment of airway obstruction in adults
3. Bronchodilator drugs
4. 2-adrenergic agonist for use in asthma
5. 2-agonist therapy
6. Guidelines on the Management of Asthma
7. Management of Asthma: A Consensus Statement
8. Theophylline
9. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand?
10. 2agonists and the risk of death and near death from asthma
11. Regular inhaled beta-agonist treatment in bronchial asthma
12. The burden of paediatric asthma
13. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients
14. A twelve month comparison of salmeterol with salbutamol in asthmatic patients
15. 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients
16. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease
17. 2-agonist
18. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma
19. Prevention of exercise-induced asthma by inhaled salmeterol xinafoate
20. A threeway crossover study comparing twice daily dosing of salmeterol 25 μg and 50 μg with placebo in children with mild to moderate reversible airways disease
21. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease - a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg)
22. Psychological treatments for childhood asthma
23. The development of child-centred, disease-specific questionnaires for living with asthma
24. Diary keeping in asthma: comparison of written and electronic methods
25. Seasonal variation and time trends in childhood asthma in England and Wales 1975–1981
26. Rising asthma admissions and self-referral